(1S,3S,4S,6S,8S,10S,11R,12S,15R,16R)-15-[(2R,5S)-6-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-6-methylheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-4,6,10-triol
| Internal ID | 05d9e870-1bd9-407d-b235-baf04a9a6472 |
| Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Cycloartanols and derivatives |
| IUPAC Name | (1S,3S,4S,6S,8S,10S,11R,12S,15R,16R)-15-[(2R,5S)-6-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-hydroxy-6-methylheptan-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-4,6,10-triol |
| SMILES (Canonical) | CC(CCC(C(C)(C)OC1C(C(C(C(O1)CO)OC2C(C(C(CO2)OC3C(C(CO3)(CO)O)O)O)O)O)O)O)C4CCC5(C4(CCC67C5C(CC8C6(C7)C(CC(C8(C)C)O)O)O)C)C |
| SMILES (Isomeric) | C[C@H](CC[C@@H](C(C)(C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@@H](CO2)O[C@H]3[C@@H]([C@](CO3)(CO)O)O)O)O)O)O)O)[C@H]4CC[C@@]5([C@@]4(CC[C@]67[C@@H]5[C@H](C[C@@H]8[C@]6(C7)[C@H](C[C@@H](C8(C)C)O)O)O)C)C |
| InChI | InChI=1S/C46H78O18/c1-21(22-10-11-43(7)35-23(49)14-26-40(2,3)28(51)15-29(52)46(26)18-44(35,46)13-12-42(22,43)6)8-9-27(50)41(4,5)64-38-33(56)31(54)34(24(16-47)61-38)63-37-32(55)30(53)25(17-59-37)62-39-36(57)45(58,19-48)20-60-39/h21-39,47-58H,8-20H2,1-7H3/t21-,22-,23+,24-,25-,26+,27+,28+,29+,30+,31-,32-,33-,34-,35-,36+,37+,38+,39+,42-,43+,44+,45-,46-/m1/s1 |
| InChI Key | LWKAIMUNJIZHDW-SIDYDICRSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C46H78O18 |
| Molecular Weight | 919.10 g/mol |
| Exact Mass | 918.51881563 g/mol |
| Topological Polar Surface Area (TPSA) | 298.00 Ų |
| XlogP | -0.10 |
| Atomic LogP (AlogP) | -0.97 |
| H-Bond Acceptor | 18 |
| H-Bond Donor | 12 |
| Rotatable Bonds | 13 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5750 | 57.50% |
| Caco-2 | - | 0.8807 | 88.07% |
| Blood Brain Barrier | - | 0.6250 | 62.50% |
| Human oral bioavailability | - | 0.8571 | 85.71% |
| Subcellular localzation | Mitochondria | 0.6150 | 61.50% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8254 | 82.54% |
| OATP1B3 inhibitior | + | 0.9371 | 93.71% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | + | 0.5250 | 52.50% |
| BSEP inhibitior | + | 0.7606 | 76.06% |
| P-glycoprotein inhibitior | + | 0.7436 | 74.36% |
| P-glycoprotein substrate | + | 0.7088 | 70.88% |
| CYP3A4 substrate | + | 0.7446 | 74.46% |
| CYP2C9 substrate | - | 0.8018 | 80.18% |
| CYP2D6 substrate | - | 0.8301 | 83.01% |
| CYP3A4 inhibition | - | 0.9241 | 92.41% |
| CYP2C9 inhibition | - | 0.8017 | 80.17% |
| CYP2C19 inhibition | - | 0.8330 | 83.30% |
| CYP2D6 inhibition | - | 0.9431 | 94.31% |
| CYP1A2 inhibition | - | 0.8946 | 89.46% |
| CYP2C8 inhibition | + | 0.7131 | 71.31% |
| CYP inhibitory promiscuity | - | 0.9524 | 95.24% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.9700 | 97.00% |
| Carcinogenicity (trinary) | Non-required | 0.6376 | 63.76% |
| Eye corrosion | - | 0.9891 | 98.91% |
| Eye irritation | - | 0.9038 | 90.38% |
| Skin irritation | - | 0.7097 | 70.97% |
| Skin corrosion | - | 0.9446 | 94.46% |
| Ames mutagenesis | - | 0.6100 | 61.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.8553 | 85.53% |
| Micronuclear | - | 0.8000 | 80.00% |
| Hepatotoxicity | - | 0.6122 | 61.22% |
| skin sensitisation | - | 0.9091 | 90.91% |
| Respiratory toxicity | + | 0.6000 | 60.00% |
| Reproductive toxicity | + | 0.7000 | 70.00% |
| Mitochondrial toxicity | - | 0.5875 | 58.75% |
| Nephrotoxicity | - | 0.6618 | 66.18% |
| Acute Oral Toxicity (c) | I | 0.6862 | 68.62% |
| Estrogen receptor binding | + | 0.8100 | 81.00% |
| Androgen receptor binding | + | 0.7679 | 76.79% |
| Thyroid receptor binding | - | 0.5270 | 52.70% |
| Glucocorticoid receptor binding | + | 0.6619 | 66.19% |
| Aromatase binding | + | 0.6801 | 68.01% |
| PPAR gamma | + | 0.7743 | 77.43% |
| Honey bee toxicity | - | 0.6082 | 60.82% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.6100 | 61.00% |
| Fish aquatic toxicity | + | 0.8309 | 83.09% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.10% | 91.11% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.24% | 97.25% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.02% | 97.09% |
| CHEMBL4302 | P08183 | P-glycoprotein 1 | 94.11% | 92.98% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.13% | 94.45% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 92.99% | 95.89% |
| CHEMBL2581 | P07339 | Cathepsin D | 92.74% | 98.95% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 92.18% | 96.61% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 91.31% | 97.79% |
| CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 90.67% | 100.00% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 90.59% | 95.58% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 89.96% | 97.14% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 89.95% | 100.00% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 89.90% | 96.09% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 89.59% | 93.18% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 89.50% | 91.03% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 88.00% | 95.93% |
| CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 87.31% | 95.71% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 87.12% | 99.17% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 86.38% | 95.50% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 85.81% | 98.05% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 85.75% | 96.31% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 85.63% | 99.00% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 85.54% | 95.17% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 85.47% | 92.88% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 85.42% | 89.00% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 85.29% | 97.29% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 85.10% | 91.24% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 84.81% | 95.89% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 84.74% | 98.75% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 84.65% | 96.47% |
| CHEMBL241 | Q14432 | Phosphodiesterase 3A | 84.51% | 92.94% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 84.41% | 90.24% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 84.19% | 100.00% |
| CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 84.02% | 96.77% |
| CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR | 83.92% | 92.78% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 83.34% | 92.86% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 81.96% | 95.71% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 81.69% | 96.90% |
| CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 81.61% | 82.50% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 81.13% | 97.47% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 80.99% | 96.21% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 80.78% | 97.86% |
| CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 80.78% | 91.07% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 80.63% | 100.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Oxytropis myriophylla |
| PubChem | 10975055 |
| LOTUS | LTS0235538 |
| wikiData | Q105158356 |